{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:18:44Z","timestamp":1787635124789,"version":"build-2736575974"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Parkinson\u2019s disease (PD) is characterized by progressive loss of dopaminergic neurons in the substantia nigra and pathological aggregation of\n                      <jats:italic>\u03b1<\/jats:italic>\n                      -synuclein, while early diagnosis and disease stratification remain constrained by the lack of sensitive and specific biomarkers. Exosomes carry proteins, lipids, and diverse nucleic acids and mediate intercellular communication; they may participate in\n                      <jats:italic>\u03b1<\/jats:italic>\n                      -synuclein propagation and neuroinflammation and have become a research focus as biomarkers and delivery vehicles due to their stability and potential to cross the blood\u2013brain barrier.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Original articles and reviews published between January 1, 2005 and December 31, 2025 were retrieved from the Web of Science Core Collection (WoSCC) and Scopus; 1,486 publications were included after merging and deduplication. CiteSpace, VOSviewer, Bibliometrix, and Microsoft Excel were used for bibliometric and visualization analyses, covering publication output, contributing countries and institutions, authors, journals, citation counts, and keyword trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PD-related exosome research spanned 63 countries, with publication output accelerating markedly after 2019 and peaking in 2023 (231 articles), accumulating 72,631 citations. China (427 articles, 28.7%) and the United States (238 articles, 16%) were the leading contributors, with the United States exhibiting a more prominent hub role in international collaboration networks. Taipei Medical University and Capital Medical University were among the most productive institutions; Zhang, Jing, and Shi, Min were among the most influential authors.\n                      <jats:italic>International Journal of Molecular Sciences<\/jats:italic>\n                      served as a core publication venue. Keyword clustering revealed three main research lines: disease models and clinical context; biofluid-derived exosomal biomarkers and diagnostic evaluation; and mechanistic studies on\n                      <jats:italic>\u03b1<\/jats:italic>\n                      -synuclein propagation and neuroinflammation. Temporal evolution indicated a shift from mechanistic exploration toward clinical translation, with \u201cengineered exosomes,\u201d \u201cdelivery,\u201d and \u201cstem cell therapy\u201d emerging rapidly in recent years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PD-related exosome research is undergoing sustained expansion with an increasingly translational orientation, and its focus shifting from pathological mechanisms toward biofluid biomarker development and engineered exosome-based delivery strategies. Mapping this knowledge landscape facilitates identification of key teams and emerging directions, providing a reference for methodological standardization, multicenter clinical validation, and interdisciplinary collaboration to advance clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1880805","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:22Z","timestamp":1787631802000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the research landscape of exosomes in Parkinson\u2019s disease: a bibliometric analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuqi","family":"Liu","sequence":"first","affiliation":[{"name":"The Sixth Hospital of Guiyang","place":["Guiyang, China"]},{"name":"The First Clinical Medical College of Guizhou University of Traditional Chinese Medicine","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Zhejiang Chinese Medicine University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Guizhou University of Traditional Chinese Medicine","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wang","sequence":"additional","affiliation":[{"name":"Weng'an County People's Hospital","place":["Weng'an, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/jnnp-2023-332974","article-title":"Exercise as medicine in Parkinson\u2019s disease","volume":"95","author":"Langeskov-Christensen","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/s41467-024-49949-9","article-title":"Neuroimaging and fluid biomarkers in Parkinson\u2019s disease in an era of targeted interventions","volume":"15","author":"Zarkali","year":"2024","journal-title":"Nat Commun"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev-physiol-042222-024535","article-title":"Exosome-mediated impact on systemic metabolism","volume":"86","author":"Cunha","year":"2024","journal-title":"Annu Rev Physiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-021-01365-z","article-title":"The role and application of small extracellular vesicles in gastric cancer","volume":"20","author":"Wu","year":"2021","journal-title":"Mol Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"111102","DOI":"10.1016\/j.celrep.2022.111102","article-title":"Rapid macropinocytic transfer of \u03b1-synuclein to lysosomes","volume":"40","author":"Bayati","year":"2022","journal-title":"Cell Rep"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41419-020-2473-5","article-title":"Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"107908","DOI":"10.1016\/j.phrs.2025.107908","article-title":"Exosome-mediated microglia-astrocyte interactions drive neuroinflammation in Parkinson\u2019s disease with Peli1 as a potential therapeutic target","volume":"219","author":"Guo","year":"2025","journal-title":"Pharmacol Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"101764","DOI":"10.1016\/j.arr.2022.101764","article-title":"Identification of exosomal biomarkers and its optimal isolation and detection method for the diagnosis of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"82","author":"Nila","year":"2022","journal-title":"Ageing Res Rev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s13760-016-0679-1","article-title":"\u03b1-Synuclein-carrying extracellular vesicles in Parkinson\u2019s disease: deadly transmitters","volume":"117","author":"Chistiakov","year":"2017","journal-title":"Acta Neurol Belg"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e20595","DOI":"10.1016\/j.heliyon.2023.e20595","article-title":"The role of exosomes in the diagnosis of Parkinson\u2019s disease","volume":"9","author":"Shi","year":"2023","journal-title":"Heliyon"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.amepre.2014.08.021","article-title":"A bibliometric analysis of U.S.-based research on the behavioral risk factor surveillance system","volume":"48","author":"Khalil","year":"2015","journal-title":"Am J Prev Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e27437","DOI":"10.1016\/j.heliyon.2024.e27437","article-title":"Global biomarker trends in Parkinson\u2019s disease research: a bibliometric analysis","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1278323","DOI":"10.3389\/fnagi.2023.1278323","article-title":"Research progress of ferroptosis in Parkinson\u2019s disease: a bibliometric and visual analysis","volume":"15","author":"Lu","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e040950","DOI":"10.1136\/bmjopen-2020-040950","article-title":"Cross-sectional analysis of bibliometrics and altmetrics: comparing the impact of qualitative and quantitative articles in the British medical journal","volume":"10","author":"Retrouvey","year":"2020","journal-title":"BMJ Open"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jrsm.1729","article-title":"Beyond Google scholar, Scopus, and web of science: An evaluation of the backward and forward citation coverage of 59 databases\u2019 citation indices","volume":"15","author":"Gusenbauer","year":"2024","journal-title":"Res Synth Methods"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J Control Release"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current strategies for brain drug delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/awv346","article-title":"Induction of \u03b1-synuclein aggregate formation by CSF exosomes from patients with Parkinson\u2019s disease and dementia with Lewy bodies","volume":"139","author":"Stuendl","year":"2016","journal-title":"Brain"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fnmol.2019.00240","article-title":"Role of exosomes in central nervous system diseases","volume":"12","author":"Liu","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1496252","DOI":"10.3389\/fnagi.2025.1496252","article-title":"Global status and trends of exosomes in neurodegenerative diseases from 2014 to 2023: a bibliometric and visual analysis","volume":"17","author":"Wu","year":"2025","journal-title":"Front Aging Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1007\/s12035-025-04788-7","article-title":"Biology, pathology, and targeted therapy of exosomal cargoes in Parkinson\u2019s disease: advances and challenges","volume":"62","author":"Almasi","year":"2025","journal-title":"Mol Neurobiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","article-title":"Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Nat Commun"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","article-title":"microRNA-155 regulates alpha-Synuclein-induced inflammatory responses in models of Parkinson disease","volume":"36","author":"Thome","year":"2016","journal-title":"J Neurosci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neuro.2024.02.005","article-title":"Neuronal exosomal miRNAs modulate mitochondrial functions and cell death in bystander neuronal cells under Parkinson\u2019s disease stress conditions","volume":"101","author":"Currim","year":"2024","journal-title":"Neurotoxicology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jamaneurol.2023.4398","article-title":"Neuronally derived extracellular vesicle \u03b1-Synuclein as a serum biomarker for individuals at risk of developing Parkinson disease","volume":"81","author":"Yan","year":"2024","journal-title":"JAMA Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"8683877","DOI":"10.1155\/2022\/8683877","article-title":"Diagnostic test to identify Parkinson\u2019s disease from the blood sera of Chinese population: a cross-sectional study","volume":"2022","author":"Tong","year":"2022","journal-title":"Parkinson\u2019s Disease"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1007\/s11010-023-04700-8","article-title":"Biochemical study of the effect of mesenchymal stem cells-derived exosome versus L-Dopa in experimentally induced Parkinson\u2019s disease in rats","volume":"478","author":"Mohamed","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e70331","DOI":"10.1111\/cns.70331","article-title":"Dual role of exosomes in Parkinson\u2019s disease: adenine exerts a beneficial effect","volume":"31","author":"Chen","year":"2025","journal-title":"CNS Neurosci Ther"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awaa090","article-title":"Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson\u2019s disease","volume":"143","author":"Guo","year":"2020","journal-title":"Brain"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"104004","DOI":"10.1016\/j.mcn.2025.104004","article-title":"Exosome-based therapeutics: advancing drug delivery for neurodegenerative diseases","volume":"133","author":"Rai","year":"2025","journal-title":"Mol Cell Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e14738","DOI":"10.1111\/cns.14738","article-title":"Plasma exosomes impair microglial degradation of \u03b1-synuclein through V-ATPase subunit V1G1","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: a guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J Neurochem"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fnins.2017.00082","article-title":"Exosomes: origins and therapeutic potential for neurodegenerative disease","volume":"11","author":"Sarko","year":"2017","journal-title":"Front Neurosci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"32013","DOI":"10.1021\/acsami.5c05809","article-title":"Mesenchymal stem-cell-derived exosomes loaded with phosphorus dendrimers and quercetin treat Parkinson\u2019s disease by modulating inflammatory immune microenvironment","volume":"17","author":"Zhang","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e70577","DOI":"10.1111\/cns.70577","article-title":"Advances in neurodegenerative disease therapy: stem cell clinical trials and promise of engineered exosomes","volume":"31","author":"Isik","year":"2025","journal-title":"CNS Neurosci Ther"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"23014","DOI":"10.1021\/acsnano.4c04674","article-title":"Engineered extracellular vesicle-based nanoformulations that coordinate neuroinflammation and immune homeostasis, enhancing Parkinson\u2019s disease therapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s12967-023-04461-4","article-title":"FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson\u2019s disease via m6A-dependent regulation of ATM mRNA","volume":"21","author":"Geng","year":"2023","journal-title":"J Transl Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"146331","DOI":"10.1016\/j.brainres.2019.146331","article-title":"Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson\u2019s disease","volume":"1722","author":"Jiang","year":"2019","journal-title":"Brain Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"805087","DOI":"10.3389\/fnmol.2022.805087","article-title":"Contribution of autophagy-lysosomal pathway in the Exosomal secretion of alpha-Synuclein and its impact in the progression of Parkinson\u2019s disease","volume":"15","author":"Sep\u00falveda","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.2147\/IJN.S513816","article-title":"Exosome-mediated mitochondrial regulation: a promising therapeutic tool for Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"20","author":"Jung","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.ymthe.2019.08.010","article-title":"Systemic exosomal delivery of shRNA minicircles prevents parkinsonian pathology","volume":"27","author":"Izco","year":"2019","journal-title":"Mol Ther"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1021\/acsnano.3c05864","article-title":"Ultrasound-assisted CRISPRi-exosome for epigenetic modification of \u03b1-Synuclein gene in a mouse model of Parkinson\u2019s disease","volume":"18","author":"Kong","year":"2024","journal-title":"ACS Nano"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jconrel.2020.07.042","article-title":"Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: strategies and significance","volume":"326","author":"Salunkhe","year":"2020","journal-title":"J Control Release"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","article-title":"Plasma exosomal \u03b1-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease","volume":"128","author":"Shi","year":"2014","journal-title":"Acta Neuropathol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","article-title":"Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission","volume":"42","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurobiol Dis"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1880805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:24Z","timestamp":1787631804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1880805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":52,"alternative-id":["10.3389\/fneur.2026.1880805"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1880805","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1880805"}}